Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dyne Therapeutics
Biotech
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Cox named new CEO of Dyne. Ex-Madrigal US sales chief named CCO of Nuvation. Longtime NIAID leader leaves for CSO gig at Alphabet's Calico.
Max Bayer
,
Gabrielle Masson
Mar 29, 2024 9:30am
BIO CEO out the door—Chutes & Ladders
Oct 14, 2022 9:30am
Ascidian Therapeutics rises from ATP's ocean floor with $50M
Oct 12, 2022 11:34am
Novartis R&D chief Jay Bradner departs—Chutes & Ladders
Sep 2, 2022 9:30am
Dyne's DMD trial back on track after FDA lifts clinical hold
Jul 5, 2022 10:00am
Sanofi-backed Expansion nabs $80M for RNA neurodegenerative work
Sep 29, 2021 7:00am